Global Neurovascular Interventional Devices for Hemorrhagic Stroke Market

11 Pages | 14 Exhibits | Forecasts Through 2025

Order individually or subscribe to Medtech Pro and get a complete intel platform.

Overview

This report from Life Science Intelligence provides the latest market data for the Global Neurovascular Interventional Devices for Hemorrhagic Stroke Market. Information covered by this report includes:

  • unit volumes & pricing forecast from 2020-2025
  • analyses of the leading companies, and
  • global market share analysis.

This report covers the impact of COVID-19 on the neurovascular interventional devices for hemorrhagic stroke market, including a recent forecast from 2020 to 2025. COVID-19 has also impacted leading competitors, such as Abbott, Boston Scientific, Cardinal Health, Penumbra, Stryker, Terumo, and others. The report provides insights into trends, drivers, and limiters of the neurovascular devices for hemorrhagic stroke market, as well as highlights potential opportunities.

Companies Covered

Abbott

Boston Scientific

Cerenovus/J&J

Cordis Cardinal Health

Evasc

Microport

Microvention/Terumo

Micrus

Penumbra

Target/Stryker

Companies We Work With